Cervical cancer vaccination targets HPV strains 16 and 18 causing 70 percent of cases, administered as Gardasil 9 to ages 9-45 via three intramuscular doses, preventing precancerous lesions with 90 percent efficacy when given pre-exposure. Integration into school programs alongside screening sustains herd immunity, slashing incidence like Australias 50 percent drop. Boosters remain under study, but single-dose trials show promise. Dr. Munisha Sharma vaccinated a rural cohort, later noting zero high-grade CIN among recipients versus historical norms, averting hysterectomies. Her campaigns educate on myths, stressing vaccination complements Pap smears for women over 30. Nonavalent covers five more types, guarding against anogenital warts too. Side effects mimic flu shots, rare anaphylaxis managed onsite. Dr. Munisha Sharmas clinics offer catch-up for adults, bundling with wellness checks. Public health synergy amplifies impact, reducing global burden projected at 13 million cases yearly. Her advocacy pushes policy for free access, prioritizing underserved. Patients gain peace from family protection, as maternal immunity wanes. Dr. Munisha Sharma tracks seroconversion, ensuring robust response. This proactive shield empowers prevention over cure, preserving cervixes and futures affordably.
Dr. Munisha Sharma.All Rights Reserved © 2026
.jpeg)